In breast cancer, FABP4 expression was highest in the HER2 subtype and lowest in the luminal A subtype [42], and HER2 overexpression-mediated oncogenic transformation of breast cells was accompanied by increased FABP4 expression [43]. This evidence concerns the gene ERBB2 and breast cancer.